XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2017/01/31/janssen-files-opening-brief-in-infliximab-appeal/20%Monthly2018-05-25 17:42
https://www.bigmoleculewatch.com/2017/01/31/hospira-files-two-petitions-for-inter-partes-review-of-genentechs-trastuzumab-related-patents/20%Monthly2018-01-10 21:16
https://www.bigmoleculewatch.com/2017/01/31/coherus-files-four-petitions-for-inter-partes-review-of-abbvies-adalimumab-related-patent/20%Monthly2018-01-10 21:14
https://www.bigmoleculewatch.com/2017/01/31/patent-owner-files-petition-for-writ-of-mandamus-to-federal-circuit-regarding-ptab-estoppel/20%Monthly2017-05-12 17:56
https://www.bigmoleculewatch.com/2017/01/30/bms-settles-keytruda-patent-suit-against-merck/20%Monthly2018-02-02 15:57
https://www.bigmoleculewatch.com/2017/01/27/amgen-receives-positive-chmp-opinion-for-its-biosimilar-adalimumab/20%Monthly2018-01-10 21:20
https://www.bigmoleculewatch.com/2017/01/27/facility-inspections-delay-sandozs-filing-for-humira-biosimilar-in-us/20%Monthly2018-01-10 21:21
https://www.bigmoleculewatch.com/2017/01/26/supreme-court-announces-briefing-schedule-in-amgen-v-sandoz/20%Monthly2018-05-25 17:38
https://www.bigmoleculewatch.com/2017/01/25/novartiss-enbrel-biosimilar-on-hold-until-patent-case-resolved/20%Monthly2018-07-25 16:10
https://www.bigmoleculewatch.com/2017/01/25/fda-response-to-biosimilar-naming-petitions-just-issued/20%Monthly2018-01-10 21:25
https://www.bigmoleculewatch.com/2017/01/24/hospira-files-ipr-petitions-on-genentechs-trastuzumab-related-patents/20%Monthly2018-01-10 21:26
https://www.bigmoleculewatch.com/2017/01/24/trump-withdraws-from-the-tpp/20%Monthly2017-01-24 00:26
https://www.bigmoleculewatch.com/2017/01/23/janssen-v-celltrion-motions-to-exclude-or-limit-evidence-and-testimony-from-the-upcoming-trial/20%Monthly2018-07-25 16:11
https://www.bigmoleculewatch.com/2017/01/20/humira-uk-patent-trial-began-monday/20%Monthly2018-10-10 17:20
https://www.bigmoleculewatch.com/2017/01/19/coherus-announces-positive-topline-phase-iii-results-for-its-humira-biosimilar/20%Monthly2018-01-10 21:31
https://www.bigmoleculewatch.com/2017/01/18/boehringer-ingelheims-biosimilar-candidate-to-humira-accepted-for-review-by-fda-and-ema/20%Monthly2018-05-25 17:38
https://www.bigmoleculewatch.com/2017/01/18/fda-denies-abbvies-citizen-petition-on-interchangeability/20%Monthly2018-01-10 21:32
https://www.bigmoleculewatch.com/2017/01/17/fda-issued-draft-guidance-on-interchangeability/20%Monthly2017-05-12 18:53
https://www.bigmoleculewatch.com/2017/01/13/breaking-news-supreme-court-grants-petition-and-cross-petition-for-certiorari-in-amgen-v-sandoz/20%Monthly2018-05-25 17:37
https://www.bigmoleculewatch.com/2017/01/12/fda-releases-biosimilar-naming-guidance/20%Monthly2017-05-12 20:08
https://www.bigmoleculewatch.com/2017/01/12/full-federal-circuit-to-decide-whether-some-institution-decisions-are-reviewable/20%Monthly2018-07-25 16:12
https://www.bigmoleculewatch.com/2017/01/12/update-on-ipr-estoppel/20%Monthly2018-07-24 14:15
https://www.bigmoleculewatch.com/2017/01/11/fda-accepts-abla-for-mylan-biocons-proposed-herceptin-biosimilar/20%Monthly2018-01-10 21:36
https://www.bigmoleculewatch.com/2017/01/10/goodwin-publishes-biosmilars-patent-litigation-update-biosimilars-investment-guidelines/20%Monthly2018-07-24 14:16
https://www.bigmoleculewatch.com/2017/01/10/update-praluent-injunction/20%Monthly2018-05-25 17:35
https://www.bigmoleculewatch.com/2017/01/09/supreme-court-declines-to-review-personal-jurisdiction-ruling-in-drug-patent-case/20%Monthly2018-01-10 21:39
https://www.bigmoleculewatch.com/2017/01/09/the-biosimilars-litigation-landscape-for-2017/20%Monthly2017-01-09 17:50
https://www.bigmoleculewatch.com/2017/01/09/deal-watch-takeda-ariad/20%Monthly2018-01-10 21:41
https://www.bigmoleculewatch.com/2017/01/06/drug-pricing-update/20%Monthly2018-01-10 21:42
https://www.bigmoleculewatch.com/2017/01/06/big-molecule-watch-team-at-j-p-morgan-healthcare-conference-2/20%Monthly2017-01-06 17:31
https://www.bigmoleculewatch.com/2017/01/06/breaking-news-court-grants-permanent-injunction-against-sale-of-praluent-in-amgen-v-sanofiregeneron/20%Monthly2018-07-25 16:13
https://www.bigmoleculewatch.com/2017/01/05/pfizer-announces-results-from-trial-with-its-proposed-humira-biosimilar/20%Monthly2018-01-10 21:51
https://www.bigmoleculewatch.com/2017/01/04/amgen-v-sanofi-regeneron-court-denies-defendants-motion-for-jmol-and-new-trial/20%Monthly2018-05-24 21:44
https://www.bigmoleculewatch.com/2017/01/04/janssen-files-a-supplemental-brief-on-whether-hospira-may-be-liable-on-theories-of-joint-enterprise-agency-or-contract/20%Monthly2018-07-25 16:14
https://www.bigmoleculewatch.com/2017/01/03/breaking-news-ptab-grants-one-petition-and-denies-another-for-review-of-genentechs-cabilly-patent/20%Monthly2018-01-10 21:52